Pfizer, one of the world’s largest pharmaceutical companies, is coming off two years of enormous success as the world’s largest supplier of COVID vaccines and the most successful anti-viral therapeutic on the market.

Reuters Editor-in-Chief Alessandra Galloni discusses Pfizer’s next era with Bourla, as the company turns to launching new treatments while balancing the world’s call for better access to medicines with its promise of profits for shareholders.

#Live #News #Reuters #ReutersNewsmaker #Pfizer